Hjalmar Wadstrom
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Non-steroidal anti-inflammatory drugs and risk of kidney cancer: A Swedish nationwide cohort study in the general and high-use populations.
Journal: Journal of internal medicine
Published: March 10, 2025
Development and clinical implementation of an LC-HRMS method for ivacaftor, lumacaftor, tezacaftor and elexacaftor in human plasma and breast milk.
Journal: Analytical and bioanalytical chemistry
Published: June 11, 2024
Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice.
Journal: Rheumatology (Oxford, England)
Published: February 15, 2021
Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors.
Journal: Annals of the rheumatic diseases
Published: December 03, 2019
Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice: A Nationwide Cohort Study From Sweden.
Journal: JAMA internal medicine
Published: October 05, 2017
Cervical neoplasia in systemic lupus erythematosus: a nationwide study.
Journal: Rheumatology (Oxford, England)
Published: April 20, 2016
Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden.
Journal: Annals of the rheumatic diseases
Published: July 16, 2015
How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)?
Journal: Scandinavian journal of rheumatology
Published: November 08, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026